SMAD4 Mutations in Colorectal Cancer Probably Occur before Chromosomal Instability, but after Divergence of the Microsatellite Instability Pathway by Woodford-Richens, K. L., Rowan, A. J., Gorman, P., Halford, S., Bicknell, D. C., Wasan, H. S., Roylance, R. R., Bodmer, W. F., Tomlinson, I. P. M.

Get full text

APC in the regulation of intestinal crypt fission by Wasan, Harpreet S., Park, Hyun-Sook, Liu, Ken C., Mandir, Nirmala K., Winnett, Angela, Sasieni, Peter, Bodmer, Walter F., Goodlad, Robert A., Wright, Nicholas A.

Get full text

CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone by Wasan, H S, Springett, G M, Chodkiewicz, C, Wong, R, Maurel, J, Barone, C, Rosbrook, B, Ricart, A D, Kim, S, Spano, J-P

Get full text

Fibre-supplemented foods may damage your health by Wasan, Harpreet S, Goodlad, Robert A

Get full text

FOXFIRE: A Phase III Clinical Trial of Chemo-radio-embolisation as First-line Treatment of Liver Metastases in Patients with Colorectal Cancer by Sharma, R.A, Wasan, H.S, Love, S.B, Dutton, S, Stokes, J.C, Smith, J.L

Get full text

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study by Primrose, John N, Fox, Richard P, Palmer, Daniel H, Malik, Hassan Z, Prasad, Raj, Mirza, Darius, Anthony, Alan, Corrie, Pippa, Falk, Stephen, Finch-Jones, Meg, Wasan, Harpreet, Ross, Paul, Wall, Lucy, Wadsley, Jonathan, Evans, Jeff T R, Stocken, Deborah, Praseedom, Raaj, Ma, Yuk Ting, Davidson, Brian, Neoptolemos, John P, Iveson, Tim, Raftery, James, Zhu, Shihua, Cunningham, David, Garden, O James, Stubbs, Clive, Valle, Juan W, Bridgewater, John, Primrose, JN, Fox, RP, Morement, H, Chan, O, Rees, C, Ma, YT, Hickish, T, Falk, S, Finch-Jones, M, Pope, I, Corrie, P, Crosby, T, Sothi, S, Sharkland, K, Adamson, D, Wall, L, Evans, J, Dent, J, Hombaiah, U, Iwuji, C, Anthoney, A, Bridgewater, J, Cunningham, D, Gillmore, R, Ross, P, Slater, S, Wasan, H, Waters, J, Valle, JW, Palmer, D, Malik, H, Neoptolemos, J, Faluyi, O, Sumpter, K, Dernedde, U, Maduhusudan, S, Cogill, G, Archer, C, Iveson, T, Wadsley, J, Darby, S, Peterson, M, Mukhtar, AA, Thorpe, JG, Bateman, A, Tsang, D, Cummins, S, Nolan, L, Beaumont, E, Prasad, R, Mirza, D, Stocken, D, Praseedom, R, Davidson, B, Raftery, J, Zhu, S, Garden, J, Stubbs, C, Coxon, F

Get full text

Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice by Wasan, H.S. (John Radcliffe Hospital, Headington, Oxford, UK.), Novelli, M, Bee, J, Bodmer, W.F

Get full text

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial by Seymour, Matthew T, Prof, Thompson, Lindsay C, MSc, Wasan, Harpreet S, Prof, Middleton, Gary, MD, Brewster, Alison E, MD, Shepherd, Stephen F, MD, O'Mahony, M Sinead, MBBS, Maughan, Timothy S, Prof, Parmar, Mahesh, Prof, Langley, Ruth E, PhD

Get full text

Combined choriocarcinoma and yolk sac tumor arising in Barrett's esophagus by Wasan, Harpreet S., Schofield, John B., Krausz, Thomas, Sikora, Karol, Waxman, Jonathan

Get full text

Effect of flutamide on survival in patients with pancreatic cancer. No recommendations can be made by Wasan, H S

Get full text

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial by Maughan, Timothy S, Prof, Adams, Richard A, FRCP, Smith, Christopher G, BSc, Meade, Angela M, DPhil, Seymour, Matthew T, Prof, Wilson, Richard H, MD, Idziaszczyk, Shelley, MPhil, Harris, Rebecca, MSc, Fisher, David, MSc, Kenny, Sarah L, MSc, Kay, Edward, BA, Mitchell, Jenna K, BHSc, Madi, Ayman, MRCP, Jasani, Bharat, Prof, James, Michelle D, BSc, Bridgewater, John, MD, Kennedy, M John, MD, Claes, Bart, MSc, Lambrechts, Diether, PhD, Kaplan, Richard, Prof, Cheadle, Jeremy P, Prof

Get full text

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 M... by Adams, Richard A, FRCP, Meade, Angela M, DPhil, Seymour, Matthew T, Prof, Wilson, Richard H, MD, Madi, Ayman, MRCP, Fisher, David, MSc, Kenny, Sarah L, MSc, Kay, Edward, BA, Hodgkinson, Elizabeth, BPharm, Pope, Malcolm, Rogers, Penny, BSc, Wasan, Harpreet, FRCP, Falk, Stephen, MD, Gollins, Simon, DPhil, Hickish, Tamas, MD, Bessell, Eric M, PhD, Propper, David, MD, Kennedy, M John, MD, Kaplan, Richard, Prof, Maughan, Timothy S, Prof

Get full text

Results of a single-arm pilot study of 32 P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy by Ross, P J, Wasan, H S, Croagh, D, Nikfarjam, M, Nguyen, N, Aghmesheh, M, Nagrial, A M, Bartholomeusz, D, Hendlisz, A, Ajithkumar, T, Iwuji, C, Wilson, N E, Turner, D M, James, D C, Young, E, Harris, M T

Get full text

Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy by Ross, P.J., Wasan, H.S., Croagh, D., Nikfarjam, M., Nguyen, N., Aghmesheh, M., Nagrial, A.M., Bartholomeusz, D., Hendlisz, A., Ajithkumar, T., Iwuji, C., Wilson, N.E., Turner, D.M., James, D.C., Young, E., Harris, M.T.

Get full text

Making an IMPACT: A priority setting consultation exercise to improve outcomes in patients with locally advanced, recurrent and metastatic colorectal cancer by Vallance, A.E., Harji, D., Fearnhead, N.S., Acheson, A., Adams, K., Adams, R., Alsina, D., Antoniou, A., Arnott, R., Bach, S., Battersby, N., Bedford, M., Beggs, A., Belcher, E., Boulstridge, L., Boyle, K., Bradbury, J., Braun, M., Brown, E., Brown, G., Burling, D., Cameron, I., Campbell, K., Carney, K., Cecil, T., Chapman, M., Chapman, S., Chong, P., Clark, S., Crane, S., Davies, J., Davies, L., Davies, M., Dawson, C., Dawson, P., Duff, M., Demick, A., Evans, M., Fenwick, S., Galbraith, S., Gilbert, D., Griffiths, B., Hargest, R., Hill, J., Hompes, R., Huguet, E., Jenkins, J., Kapur, S., Karandikar, S., Katte, C., Kumar, N., Langman, G., Lim, M., Lopes de Azevedo-Gilbert, R., Macdonald, A., Mathur, P., Maxwell-Armstrong, C., McArthur, D., McDermott, F., McDermott, U., Mirnezami, A., Mitchell, P., Mohamed, F., Moran, B., Morris, M., Murphy, J., Nakas, A., Norris, C., O'Dwyer, S., Panagiotopoulou, I., Pellino, G., Powell, C., Renehan, A., Rowbottom, P., Sagar, P., Samuel, L., Seligmann, J., Shaikh, I., Skarrot, P., Speake, W., Stearns, A., Stylianides, N.A., Sutton, P., Swarnkar, K., Taylor, C., Tebala, G., Thorpe, G., Tiernan, J., Toogood, G., Vimalchandran, D., Walker, K., Walsh, C., Warren, O., Wasan, H., Welsh, F., Wheeler, J., Whitley, S., Wilson, M., Winter, D., Youssef, H.

Get full text

CA I9-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone by WASAN, H. S, SPRINGETT, G. M, CHODKIEWICZ, C, WONG, R, MAUREL, J, BARONE, C, ROSBROOK, B, RICART, A. D, KIM, S, SPANO, J.-P

Get full text

Clodronate for multiple myeloma by Wasan, HarpreetS, Waxman, Jonathan, Laakso, Markku

Get full text

Lesson of the Week: Failure of normalisation of (alpha) fetoprotein concentration after successful treatment of teratoma by Pandha, H S, Wasan, H S, Harrington, K, Waxman, J

Get full text

Failure Of Normalisation Of α Fetoprotein Concentration After Successful Treatment Of Teratoma by Pandha, H. S., Wasan, H. S., Harrington, K., Waxman, J.

Get full text

Effect of flutamide on survival in patients with pancreatic cancer by Bramhall, Simon, Buckels, John, Wigmore, Stephen J., Fearon, Kenneth C. H., Garden, O. James, Wasan, H. S., Greenway, Brian A.

Get full text